Related Experiment Video
Updated: Jun 10, 2025
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Noval insights and therapeutic strategies for tumor-induced kidney pathologies
Meng Wang1, Yong Han1, Chao Zhang2
1Department of Endocrinology, Songjiang Research Institute, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Abstract:
Recent progress in elucidating the role of specific antidiuretic hormones in Drosophila models has provided valuable insights into the mechanisms underlying tumor-induced renal dysfunction. Xu et al. identified the mammalian neurokinin 3 receptor (TACR3), a homolog of the G protein-coupled receptor TkR99D in fruit flies, as a potential therapeutic target for alleviating renal tubular dysfunction in mice with malignant neoplasms. Here, we commented on these findings by emphasizing the structural and evolutionary significance of TACR3 and provided an in-depth analysis of cell type specific expression of TACR3 in response to renal injury and expressional dynamics during renal carcinoma progression. The implications of these findings for transforming the therapeutic approaches to renal complications associated with oncological disorders were highlighted. We also acknowledged the limitations of current experimental models in this study and emphasized the necessary clinical validation in the future. These insights could contribute to the advancement of diagnostic and therapeutic strategies for treating tumor-related renal pathologies.
Insights
Researchers explored the mammalian neurokinin 3 receptor (TACR3) as a target for tumor-induced kidney dysfunction. This study analyzes TACR3
Area of Science:
- Oncology
- Nephrology
- Molecular Biology
Background:
- Tumor-induced renal dysfunction is a significant clinical challenge.
- Antidiuretic hormone mechanisms in Drosophila offer insights into renal pathologies.
- The mammalian neurokinin 3 receptor (TACR3), a homolog of Drosophila TkR99D, is implicated.
Purpose of the Study:
- To comment on the findings by Xu et al. regarding TACR3 as a therapeutic target.
- To analyze the structural and evolutionary significance of TACR3.
- To investigate TACR3 expression dynamics in renal injury and carcinoma progression.
Main Methods:
- Bioinformatic analysis of TACR3 structure and evolution.
- In-depth analysis of cell-type-specific TACR3 expression.
- Examination of TACR3 expressional dynamics during renal carcinoma progression.
Main Results:
- TACR3 identified as a potential therapeutic target for renal tubular dysfunction in malignant neoplasms.
- Detailed analysis of TACR3's structural and evolutionary importance.
- Characterization of TACR3 expression patterns in response to renal injury and cancer.
Conclusions:
- TACR3 holds promise for transforming therapeutic strategies for renal complications in cancer patients.
- Further clinical validation of experimental models is necessary.
- Insights contribute to advancing diagnostic and therapeutic approaches for tumor-related renal pathologies.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:28Chronic Kidney Disease III: Interprofessional Care
01:16Kidney Transplant III: Nursing Management
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:20Acute Kidney Injury V: Interprofessional Care